Abstract:Naoyuki Taniguchi The most complex post-translational modification of proteins, glycosylation, is controlled by diverse regulatory mechanisms that include the 3D structure of the protein, the complement of glycosyltransferases and glycosidases that are expressed, the transport of substrates into the endoplasmic reticulum and the Golgi, and the topographical transit of the proteins through these compartments during biosynthesis. It is not surprising, therefore, that the glycans expressed on a particular protein reflect the state of the cell that has synthesized it, be it normalcy or that of pathology. Difficulties in our ability to focus on protein glycosylation as a means to develop diagnostic and prognostic assays for particular disorders and diseases are beginning to be overcome, however, as Glycomic technologies are developed. The collection of studies published in this issue demonstrates progress in developing several tools and methodologies to analyze tissues and fluids for altered protein glycosylation, as well as for identifying particular protein glycosylation markers that are associated with the disease state. The first three contributions are largely focused on describing state-of-the-art technologies and reagents to perform glycoproteomics and identify potential biomarkers. The first, from G. Hart’s laboratory [1], summarizes current glycoproteomics and mass spectrometric approaches to identify site-specific glycosylation with the monosaccharide O-GlcNAc. This post-translational modification is as ubiquitous and its functions as diverse as phosphorylation, and there are indications that it may be able to identify the pre-diabetic state. Next, K. Ueda presents an overview of strategies for identification of potential cancer glycan markers using glycoproteomic strategies [2]. R. Cummings’ laboratory [3] then presents a comprehensive review of the utility of the Tn and sialyl-Tn antigens in identifying various cancers and other diseases and disorders, such as IgA nephropathy, concentrating on the mechanism that causes loss of the T-synthase and production of these antigens, namely, mutations in the molecular chaperone, Cosmc. The next three papers describe progress using lectin-based analyses to discover novel biomarkers. B. Haab’s laboratory [4] discusses a novel methodology to predict O-glycan motifs by analyzing the binding of multi-lectins to the Consortium for Functional Glycomics glycan array, and applying this method to identify and distinguish motifs on MUC1 synthesized and secreted by eight cultured pancreatic cancer cell lines. Narimatsu’s laboratory [5] discusses a lectin/antibody-based assay to quantify a specific glycoform of Mac-2 binding protein (galectin3) in serum as a marker for liver fibrosis. Next, Miyoshi’s laboratory [6] has developed an assay for serum Mac-2 binding protein that can assist diagnosis of nonalcoholic fatty liver disease and, predicting severity of this disease and distinguishing between this disease and simple steatosis. The final four contributions describe somewhat more advanced glycan markers for particular diseases. Kitazume and Taniguchi, et al. [7] describe a glycoform of amyloid b peptide secreted by vascular endothelial cells that is O-glycosylated. This glycoform has the potential to be a biomarker for acute coronary syndrome. Miyamoto and Lebrilla [8] have evaluated to protein enrichment techniques to evaluate glycan differences in serum and on IgG to demonstrate differences in serum from non-diseased and lung cancer patients. Drake’s laboratory [9] has developed glycoproteomic methods to analyze expressed prostatic secretions on total glycoproteins and prostatic acid phosphatase and showed an association of an increase in bisected N-linked glycans, and loss of highly branched N-linked glycans, with prostatic carcinoma severity. Finally, Mehta and colleagues [10] demonstrated that N-linked glycan analysis of total serum glycoproteins could distinguish well hepatocellular carcinoma from cirrhosis. When combined with alpha-fetoprotein levels, the sensitivity of the method increased to 95% with a specificity of 90%, which is very impressive.

Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound

A Critical Role of a Plant-Specific TFIIB-related Protein, BRP1, in Salicylic Acid-Mediated Immune Response

Tetrapyrrole Biosynthesis Pathway Regulates Plastid-to-nucleus Signaling by Controlling Plastid Gene Expression in Plants

Rydberg Molecule-Induced Remote Spin Flips.

SPX4 Negatively Regulates Phosphate Signaling and Homeostasis through Its Interaction with PHR2 in Rice.

Translationally controlled tumor protein interacts with TaCIPK23 to positively regulate wheat resistance to Puccinia triticina

TaClpS1, negatively regulates wheat resistance against Puccinia striiformis f. sp. tritici

A serine-rich effector from the stripe rust pathogen targets a Raf-like kinase to suppress host immunity

TaDIR1-2, a Wheat Ortholog of Lipid Transfer Protein AtDIR1 Contributes to Negative Regulation of Wheat Resistance against Puccinia striiformis f. sp. tritici

A Leucine-Rich Repeat Receptor-like Kinase TaBIR1 Contributes to Wheat Resistance against Puccinia striiformis f. sp. tritici

PHOSPHATE RESPONSE 1 Family Members Act Distinctly to Regulate Transcriptional Responses to Phosphate Starvation.

USE OF INTENSE ULTRASOUND IN NEUROLOGICAL RESEARCH

Chloroplast elongation factors break the growth–immunity trade-off by simultaneously promoting yield and defence

Glycan Biomarker Discovery

Active photosynthetic inhibition mediated by MPK3/MPK6 is critical to effector-triggered immunity

A thaumatin‐like effector protein suppresses the rust resistance of wheat and promotes the pathogenicity of Puccinia triticina by targeting TaRCA

Pulmonary mycosis in AIDS.

The small GTP-binding protein TaRop10 interacts with TaTrxh9 and functions as a negative regulator of wheat resistance against the stripe rust

The rice E3 ubiquitin ligase-transcription factor module targets two trypsin inhibitors to enhance broad-spectrum disease resistance

PHOSPHATE STARVATION RESPONSE1 (PHR1) interacts with JASMONATE ZIM-DOMAIN (JAZ) and MYC2 to modulate phosphate deficiency-induced jasmonate signaling in Arabidopsis

WRKY33 negatively regulates anthocyanin biosynthesis and cooperates with PHR1 to mediate acclimation to phosphate starvation